Skip to content

Clinical trials

Coronary Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20052
20083
20093
20102
20111
20123
20142
20181
20191
20201
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices7
Amgen2
GlaxoSmithKline2
Hoffmann-La Roche2
Pfizer2
Amarin Pharma Inc.1
AstraZeneca1
Bayside Health1
Cadrock Pty. Ltd.1
Dr Peter Barlis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease28
Coronary Artery Disease11
Myocardial Ischemia9
Cardiovascular Diseases8
Coronary Stenosis8
Coronary Restenosis7
Atherosclerosis4
Heart Diseases4
Vascular Diseases4
Dyslipidemias3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.